Apollo Proton Cancer Centre Announces India’s First Robotic Surgery Program for Ovarian Cancer !!
First time in India, patient with dual cancer diagnosis, undergoes Robotic CRS with HIPEC
Chennai, May 16, 2024 Apollo Proton Cancer Centre (APCCI, South Asia’s first and largest proton therapy announces the launch of the Robotic Surgery Programme for Ovarian Cancers and the successful completion of India’s First Robotic Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in two unique cases of advanced ovarian cancers. These medical milestones mark a significant advancement in the regional cancer treatment landscape, offering new node and improved care standards for patients batting this severe illness
48-year-oid Vis: Thara (name changed on request) from Guwahati, was suffering from carcinoma of the ovary with omental and peritoneal metastases. After receiving three cycles of nenadjuvant chemotherapy, which significantly reduced her cancer burden, she underwent a complex robotic-assisted interval cytoreductive surgery The procedure inciuced extensive surgical clearance. followed by HIPEC using a closed technique, which ensures precise temperature control and optimal drug distributiσει She was also detected with breast cancer during her work up, she could undergo surgery for breast cancer in the sanic sitting. The use of robotic system enabled both the surgeries to be dore with minimal morbidity and the patient was discharged in three days.
The robotic platform enabled both surgeries to be done with minimal morbidity; patient was discharged in three days
Demonstration of Versatility and reach of robotic surgery in treating complex cancer
Vis, Amala, (name changed or request) 3 40-year-old lady from Chenna, was bating against recurrence of a rare tumor calleo-extrauterine endometrial stromal sarcoma She underwent a similar extensive rabotic cytoreductive surgery, which included the removal of multiple cancer-affected tissues and organs, demonstrating the versatility and reach of robotic surgery in treating complex cancer recurrenses.
Compared to open CRS, robotic-assisted interval cytoreductive surgery reduce the nospital stay from over 10 days to just three days, minimizes a ood loss, anc decreased post-operative pain. The robotic system facilitates the c’iniciar’s to access multiple ceen areas of the abdomen effectively and clear the disease from there. Patients benefit from a faste return of howe function and culcker resumption of normal activities, including timely continuation of adjuvant therapies. This, min mally invasive technology, not only enhances patient.comfort and recovery but also alig’s with the best outcomes.
Dr. Venkat P, Senior Consultant – Surgical Oncology, Apollo Proton Cancer Centre, sald Al Apollo Proton Cancer Centre, we are continually advancing our capabilities in robotic cechnology. The dual surgeries for advariced ovarian cancer utlized cutting-edge robotic systems that provide superior precision and flexibility. The intricate nature of this surgery involving multiple resections and HIPEC showcases the remarkab e precision and dexterity offered by robotic technology in these particular cases, the ability to achieve optimal cytoreduction while preserving healthy tissues is crucial for the patient’s ong-term prognous”
Dr. Priya Kapoor, Consultant-Surgical Oncology, Apollo Proton Cancer Centre, said, “The new approach Robotic Cytoreductive Surgery with HPEC sa testament to our meticulous planning and the precision that robot csurgery offers. For our patients, this meant less invasive procedures and targeted chemotherapy delivery at e evated temperatures, directly at the site of the tumor. This approach significantly enhances the efficacy of the treatment while reducing the typical complications associated with open surgeries”
Ms. Amala said, “Robatic Surgery helped me to recover quick y due to the small insert on and less pain. The Doctors exp’ained the procedures clearly which helped me to prepare myself for the surge’v
At Apollo Protor Cancer Centre, the commitment towards advancing cancer care is underscored with the atest technology. They continue to signeer significant advancements in medical treatments, reinforcing its position as a leader n healthcare and cancer care Innovation These landmark surgeries e Tami Naou Highlight the centre’s ongoing commitment to bringing, woric-class healthcare to the patients and setting new benchmarks in cancer care.
Winning OverCancer
About Apollo Proton Cancer Centre (APCC), Chennai, India:
Apollo Proton Cancer Centre is the most advanced Cancer Centre and the first Proton Therapy Centre in South Asia & the Middle East and india’s first JEI-accredited Cancer nospital, it is the country’s first and orly hospital to nave proton beam therapy in sinical operation. At the bedrock of ARCC’s approach to treating cancer is its robust multi-disciplinary platform, highly skilled professionals who come together to forma cancer management team (CM). Each M focused on delivering the best possible outcomes for mm patients. An added feather in the cap is the recent launch of India’s first & only site-specic Robotic Oncology Program
